aid: draig-therapeutics
name: Draig Therapeutics
description: >-
  Draig Therapeutics is a clinical-stage biopharmaceutical company developing
  transformative, best-in-class therapies for major neuropsychiatric disorders,
  including Major Depressive Disorder. A Cardiff University spinout co-founded
  with SV Health Investors, Draig ("dragon" in Welsh) leverages its founders'
  expertise in modulating the core glutamate/GABA pathways that underlie
  synaptic excitation and inhibition imbalance in the brain. Its pipeline is led
  by DT-101, a next-generation AMPA receptor positive allosteric modulator (PAM)
  advancing toward Phase 2 in MDD, alongside DT-201 and DT-301, subtype-selective
  GABAA receptor modulators. The company launched from stealth in June 2025 with
  a $140 million (£107 million) oversubscribed Series A led by Access
  Biotechnology, with participation from Canaan Partners, SR One, Sanofi Ventures,
  Schroders Capital, SV Health Investors, and ICG. Added to the API Evangelist
  network as a portfolio company of Canaan Partners.
url: https://raw.githubusercontent.com/api-evangelist/draig-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- canaan-partners
x-industry: Biotechnology
x-headquarters: Cardiff, Wales, United Kingdom
x-tier: profiled
x-tier-reason: portfolio-lead
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-18'
image: https://draigtherapeutics.com/wp-content/uploads/2026/05/cropped-Draig_favicon-192x192.png
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Therapeutics
- Neuroscience
- Neuropsychiatry
- Drug Discovery
- Clinical Stage
- CNS
apis: []
common:
- type: DomainSecurity
  url: security/draig-therapeutics-domain-security.yml
- type: Website
  url: https://draigtherapeutics.com/
- type: About
  url: https://draigtherapeutics.com/our-approach/
- type: Support
  url: https://draigtherapeutics.com/contact/
- type: PrivacyPolicy
  url: https://draigtherapeutics.com/privacy-policy/
- type: LinkedIn
  url: https://www.linkedin.com/company/draigtherapeutics/
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence